Attention IASLC Voting Members!!

Check your email for "Your Vote Matters: Cast Your Ballot on IASLC Bylaws Today" to cast your ballot, or contact membership@iaslc.org

IASLC News

Timely and relevant thoracic oncology news brought to you by the only truly global association dedicated to the multidisciplinary study of lung cancer.
ILCN News
ILCN

The IASLC Lung Cancer News (ILCN) is the IASLC's official news medium for thoracic oncology specialists around the globe. ILCN provides its international audience with timely and relevant lung cancer news on topics across specialties and interests, such as novel clinical trial design and statistics, overcoming barriers to NGS testing, tobacco control and smoking/vaping cessation, patient-driven research, patient communication and care delivery during COVID, and more. Only the IASLC—the only international association dedicated to the study of lung cancer—can bring you multidisciplinary nuanced perspectives on daily clinical conundrums and the latest novel research by the true experts in the field.

Press releases_2017 opening press conference

For The Media

If you are a member of the media looking for more information about an IASLC-related event or program, please reach out to our media contacts.

IASLC News_landing_Communications Committee box

Communications Committee

Comprising 30 members from around the world and across all areas of lung cancer patient care, including advocacy, the Communications Committee is eager to spotlight IASLC's programs and resources, as well as engage with members about important topics.

Interested in Advertising?

WCLC News Spread

IASLC is now offering a web platform to communicate its science, research, patient care and conference coverage to its members and affiliates. The official website ILCN.org, will provide industry and their media agencies an online marketing solution utilizing ad server technology to deliver meaningful impressions and measure audience engagement. 

Creating Community…
Connect with IASLC and keep up-to-date with our latest news, stories, and insights.

Facebook